Microscopic Polyangiitis
Information
- Disease name
- Microscopic Polyangiitis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05716334 | Active, not recruiting | Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator | June 15, 2021 | September 15, 2025 | |
| NCT00307593 | Completed | N/A | RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides | May 2004 | June 2007 |
| NCT00307671 | Completed | Phase 4 | Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years | July 2005 | July 2011 |
| NCT00315393 | Completed | Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis | April 2006 | December 2019 | |
| NCT00104299 | Completed | Phase 2/Phase 3 | Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis | January 2005 | January 2010 |
| NCT00405860 | Completed | Phase 1 | CellCept in p-ANCA Vasculitis | December 2002 | July 2008 |
| NCT00430105 | Completed | Phase 2/Phase 3 | Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides | February 1998 | April 2004 |
| NCT00748644 | Completed | Phase 3 | Efficacy Study of Two Treatments in the Remission of Vasculitis | October 2008 | June 2013 |
| NCT00753103 | Completed | Phase 2 | Anti-Cytokine Therapy for Vasculitis | January 2003 | July 2006 |
| NCT05703802 | Completed | Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia. | February 1, 2022 | November 1, 2022 | |
| NCT04280601 | Completed | N/A | PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis | August 1, 2020 | March 1, 2023 |
| NCT03410290 | Completed | Journey of Patients With Vasculitis From First Symptom to Diagnosis | January 11, 2018 | May 21, 2018 | |
| NCT02476292 | Completed | Impact of Vasculitis on Employment and Income | June 2015 | January 2016 | |
| NCT02190942 | Completed | VCRC Patient Contact Registry Patient-Reported Data Validation Study | May 2014 | June 18, 2019 | |
| NCT02190929 | Completed | Educational Needs of Patients With Systemic Vasculitis | March 2012 | February 2014 | |
| NCT01613599 | Completed | An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis | June 20, 2012 | April 28, 2017 | |
| NCT01697267 | Completed | Phase 3 | Rituximab Vasculitis Maintenance Study | April 2013 | November 21, 2019 |
| NCT02190916 | Completed | Vasculitis Illness Perception (VIP) Study | October 2011 | October 2013 | |
| NCT01731561 | Completed | Phase 3 | Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis | November 16, 2012 | April 5, 2016 |
| NCT02169219 | Completed | Phase 4 | Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis | June 2014 | November 1, 2017 |
| NCT02176070 | Completed | Reproductive Health in Men and Women With Vasculitis | February 2011 | March 2012 | |
| NCT06350110 | Not yet recruiting | Phase 1/Phase 2 | Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) | November 10, 2024 | December 28, 2025 |
| NCT06294236 | Recruiting | Phase 1 | Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) | April 29, 2024 | March 2028 |
| NCT01241305 | Recruiting | One-Time DNA Study for Vasculitis | October 2010 | August 2027 | |
| NCT04316494 | Recruiting | Phase 4 | Hydroxychloroquine in ANCA Vasculitis Evaluation | December 17, 2020 | March 2025 |
| NCT02006134 | Recruiting | Pediatric Vasculitis Initiative | January 2013 | March 2025 | |
| NCT02967068 | Recruiting | VCRC Tissue Repository | November 2016 | December 2025 | |
| NCT03482479 | Recruiting | Phase 2 | Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis | February 4, 2019 | December 31, 2024 |
| NCT02474888 | Terminated | Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis | September 15, 2015 | June 12, 2020 | |
| NCT05376319 | Terminated | Phase 2 | PR3-AAV Resilient Remission or PRRR | June 30, 2023 | May 7, 2024 |
| NCT01586858 | Terminated | Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study | May 2012 | May 15, 2014 | |
| NCT01408836 | Terminated | Phase 2/Phase 3 | Plasma Exchange for Renal Vasculitis | March 1995 | December 2003 |
| NCT00400075 | Unknown status | Phase 4 | CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors | July 1996 | |
| NCT01729624 | Unknown status | PRO Development for ANCA Associated Vasculitis | September 2012 | August 2015 | |
| NCT02198248 | Unknown status | Phase 4 | Low-dose Glucocorticoid Vasculitis Induction Study | October 2014 | June 2021 |
| NCT01405807 | Unknown status | Phase 4 | Alemtuzumab for ANCA Associated Refractory Vasculitis | February 2011 | March 2014 |
| NCT01066208 | Unknown status | American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis | January 2011 | December 2018 | |
| NCT00751517 | Unknown status | Phase 2 | Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides | ||
| NCT02126098 | Unknown status | Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis | May 2014 | December 2017 | |
| NCT01598857 | Withdrawn | Phase 2 | BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis | December 2014 |
- OrphaNumber from OrphaNet (Orphanet)
- 727
- ICD10 preferred id (Insert disease from ICD10)
- D0010452
- ICD10 class code (Insert disease from ICD10)
- M31.7
- MeSH unique ID (MeSH (Medical Subject Headings))
- D055953